Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
出版年份 2013 全文链接
标题
Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 108, Issue 12, Pages 2582-2589
出版商
Springer Nature
发表日期
2013-05-22
DOI
10.1038/bjc.2013.248
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
- (2012) Antje Krohn et al. AMERICAN JOURNAL OF PATHOLOGY
- Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
- (2012) J Cuzick et al. BRITISH JOURNAL OF CANCER
- An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy
- (2012) Emmanuel S. Antonarakis et al. CANCER
- Novel, gross chromosomal alterations involving PTEN cooperate with allelic loss in prostate cancer
- (2012) Alison H M Reid et al. MODERN PATHOLOGY
- PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients
- (2011) T. L. Lotan et al. CLINICAL CANCER RESEARCH
- Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study
- (2011) Jack Cuzick et al. LANCET ONCOLOGY
- SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
- (2011) Zhihu Ding et al. NATURE
- Molecular classification of prostate cancer using curated expression signatures
- (2011) E. K. Markert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer
- (2010) A H M Reid et al. BRITISH JOURNAL OF CANCER
- An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extent
- (2010) Ramzi Rajab et al. MODERN PATHOLOGY
- Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohort
- (2010) Ramzi Rajab et al. VIRCHOWS ARCHIV
- A Robust Immunohistochemical Assay for Detecting PTEN Expression in Human Tumors
- (2010) Zaina Sangale et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer
- (2009) Sak Kudahetti et al. BJU INTERNATIONAL
- Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement
- (2009) C S Foster et al. BRITISH JOURNAL OF CANCER
- Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study
- (2009) D M Berney et al. BRITISH JOURNAL OF CANCER
- Is PTEN loss associated with clinical outcome measures in human prostate cancer?
- (2008) P McCall et al. BRITISH JOURNAL OF CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started